Earnings
BLCM
3.850
-7.67%
-0.320
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
7.14M
7.14M
--
--
29.97M
62.44M
--
--
--
94.51M
--
-87.36M
-2.93M
--
-22.18M
-2.93M
-112.48M
--
-112.48M
--
-112.48M
-112.48M
--
--
-24.01
FY 2018-12-31
1.12M
1.12M
436.00K
684.00K
25.00M
71.15M
--
--
--
96.59M
--
-95.47M
-2.56M
-10.00K
--
-2.57M
-98.04M
0.00
-98.04M
--
-98.04M
-98.04M
0.00
--
-24.37
FY 2017-12-31
185.00K
185.00K
864.00K
-679.00K
21.05M
65.66M
--
--
864.00K
89.36M
--
-89.17M
-2.62M
11.00K
--
-2.61M
-91.78M
0.00
-91.78M
--
-91.78M
-91.78M
0.00
--
-28.94
FY 2016-12-31
388.00K
388.00K
580.00K
-192.00K
16.93M
51.26M
--
--
580.00K
68.77M
--
-68.38M
-851.00K
-10.00K
0.00
-861.00K
-69.24M
--
-69.24M
--
-69.24M
-69.24M
--
--
-25.69
FY 2015-12-31
282.00K
282.00K
3.18M
-2.90M
12.67M
33.56M
--
--
3.18M
49.42M
--
-49.13M
629.00K
-42.00K
0.00
587.00K
-48.55M
--
-48.55M
--
-48.55M
-48.55M
--
--
-18.43

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out BLCM latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Bellicum Pharms recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.